Bansal Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 14-12-2024
- Revenue 12.60%
(FY 2023)
- Profit 7.10%
(FY 2023)
- Ebitda -20.93%
(FY 2023)
- Net Worth 19.41%
(FY 2023)
- Total Assets 2.17%
(FY 2023)
About Bansal Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Sanjay Bansal, Vinay Kumar, Aman Bansal, and Ten other members serve as directors at the Company.
- CIN/LLPIN
U24231DL1999PTC100411
- Company No.
100411
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNew Delhi, Delhi
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bansal Pharmachem?
Board Members(13)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Stuti Mittal  | Director | 01-Apr-2022 | Current |
| Sanjay Bansal | Director | 25-Jun-1999 | Current |
| Vinay Kumar | Director | 18-Jul-2000 | Current |
| Aman Bansal | Director | 04-Oct-2011 | Current |
| Rashmi Bansal | Director | 04-Oct-2011 | Current |
| Sachin Bansal | Director | 04-Oct-2011 | Current |
Financial Performance of Bansal Pharmachem.
Bansal Pharmachem Pvt. Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 12.6% increase. The company also saw a slight improvement in profitability, with a 7.1% increase in profit. The company's net worth Soared by an impressive increase of 19.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bansal Pharmachem?
Unlock access to Bansal Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Brij Mohan Bansal Medicare Logistics Private LimitedActive 10 years 7 monthsSanjay Bansal, Aman Bansal and 2 more are mutual person
- Ab & Pj Retail Ventures Private LimitedActive 1 year 19 days
Aman Bansal, Sachin Bansal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 08 May 2010 | ₹1.00 M | Open |
How Many Employees Work at Bansal Pharmachem?
Bansal Pharmachem has a workforce of 96 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bansal Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
